Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Cohbar, Inc. | 200 000 | déclaré | 26 avr. 2021 | tx 2+400 000 |
| MIMEDX GROUP, INC. | 117 024 | déclaré | 13 juin 2023 | tx 5+117 024 |
| AEROGEN INC | 20 000 | déclaré | 27 juil. 2004 | tx 1+20 000 |
| Revance Therapeutics, Inc. | 12 000 | déclaré | 14 mai 2020 | tx 25+541 251−462 418 |
| Corium International, Inc. | 0 | déclaré | 27 nov. 2018 | tx 14+89 342−129 187 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 13 juin 2023 | GRANT_AWARD | MIMEDX GROUP, INC. | 35 354 | 4.95 USD | |
| 07 juin 2022 | GRANT_AWARD | MIMEDX GROUP, INC. | 44 191 | 3.96 USD | |
| 27 mai 2021 | GRANT_AWARD | MIMEDX GROUP, INC. | 17 056 | 10.26 USD | |
| 28 avr. 2021 | GRANT_AWARD | MIMEDX GROUP, INC. | 16 339 | 10.71 USD | |
| 28 avr. 2021 | GRANT_AWARD | MIMEDX GROUP, INC. | 4 084 | 10.71 USD | |
| 26 avr. 2021 | GRANT_AWARD | Cohbar, Inc. | 200 000 | 0.00 USD | deriv |
| 14 mai 2020 | GRANT_AWARD | Revance Therapeutics, Inc. | 6 000 | 0.00 USD | |
| 14 mai 2020 | GRANT_AWARD | Revance Therapeutics, Inc. | 12 000 | 0.00 USD | deriv |
| 09 mai 2019 | GRANT_AWARD | Revance Therapeutics, Inc. | 4 500 | 0.00 USD | |
| 09 mai 2019 | GRANT_AWARD | Revance Therapeutics, Inc. | 9 000 | 0.00 USD | deriv |
| 08 févr. 2019 | GRANT_AWARD | Cohbar, Inc. | 200 000 | 0.00 USD | deriv |
| 27 nov. 2018 | OTHER | Corium International, Inc. | 34 203 | 12.50 USD | |
| 27 nov. 2018 | OTHER | Corium International, Inc. | 7 920 | 12.50 USD | deriv |
| 27 nov. 2018 | OTHER | Corium International, Inc. | 12 000 | 12.50 USD | deriv |
| 27 nov. 2018 | OTHER | Corium International, Inc. | 15 000 | 12.50 USD | deriv |
| 27 nov. 2018 | OTHER | Corium International, Inc. | 15 000 | 12.50 USD | deriv |
| 27 nov. 2018 | OTHER | Corium International, Inc. | 12 000 | 12.50 USD | deriv |
| 10 mai 2018 | GRANT_AWARD | Revance Therapeutics, Inc. | 3 000 | 0.00 USD | |
| 10 mai 2018 | GRANT_AWARD | Revance Therapeutics, Inc. | 6 000 | 0.00 USD | deriv |
| 16 mars 2018 | EXERCISE | Revance Therapeutics, Inc. | 1 333 | 2.55 USD | |
| 16 mars 2018 | EXERCISE | Revance Therapeutics, Inc. | 4 000 | 2.55 USD | |
| 16 mars 2018 | SALE | Revance Therapeutics, Inc. | 5 333 | 31.51 USD | |
| 16 mars 2018 | EXERCISE | Revance Therapeutics, Inc. | 1 333 | 0.00 USD | deriv |
| 16 mars 2018 | EXERCISE | Revance Therapeutics, Inc. | 4 000 | 0.00 USD | deriv |
| 01 déc. 2017 | GRANT_AWARD | Corium International, Inc. | 15 000 | 0.00 USD | deriv |